SCHEMBL17049296

SCHEMBL17049296

Cc1ccc(S(=O)(=O)n2ccc3ccc(I)cc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
HTT P42858 3/20 0.47
MAPT P10636 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAPGEF4 Q8WZA2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
PKM P14618 1/20 0.46
HTR1A P08908 1/20 0.45
DRD2 P14416 1/20 0.45
FABP4 P15090 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17049298 0.88 HTR6 (0.56) HTR6MEN1KMT2AL3MBTL1HTT
SCHEMBL1898211 0.88 HTR6 (0.56) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL2573218 0.82 MEN1 (0.60) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL1892821 0.82 HTR6 (0.54) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL1306928 0.82 HTR6 (0.54) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL29408218 0.82 MEN1 (0.60) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL22980669 0.80 HTR6 (0.78) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL1892670 0.80 HTR6 (0.78) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL2134757 0.80 CYP2A6 (0.51) HTR6MEN1KMT2ASLC1A3SLC1A2
SCHEMBL18161364 0.80 HTR6 (0.49) HTR6MEN1KMT2ASLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed
WO-2015131100-A1 LIGAND-CONTROLLED C(SP3)-H ARYLATION AND OLEFINATION IN SYNTHESIS OF UNNATURAL CHIRAL ALPHA AMINO ACIDS THE SCRIPPS RESEARCH INSTITUTE (US) 2015-09-03 WO disclosed